← Leaderboards
Raymond Luke Comenzo
Tufts Medical Center
$1,901,978
Attributed
$2,159,609
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $862K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,159,609 · 2
By mechanism
R01$1,644,347 · 1
R21$515,262 · 1
Top collaborators
- Suzanne Lentzsch2 shared
Others in their field
Other Emerging Leaders on “Patient Screening”
- Leonard Freedman · Leidos Biomedical Research, Inc.$263,844,404
- Lynn Briscoe · Leidos Biomedical Research, Inc.$96,600,220
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Jennifer Marie Suga · Kaiser Foundation Research Institute$32,396,809
- Bryan Faller · Decatur Memorial Hospital$29,346,991
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
Research focus
Patient ScreeningUniversitiesImmunoglobulin Variable RegionPathologicProteinsSymptomsDiagnosisHeartMarrowNext Generation SequencingPlasma CellsPrimary Amyloidosis Of Light Chain TypePublic HealthScreeningCessation Of LifeDepositionEarly DiagnosisGenesLaboratoriesLightMonoclonal GammapathiesMultiple MyelomaCellsBlood
Grant awards (4)
Screening for AL Amyloidosis in Smoldering Multiple Myeloma$782,391
R01 · FY2025 · CA · contact PI
Screening for AL Amyloidosis in Smoldering Multiple Myeloma$861,956
R01 · FY2024 · CA · contact PI
Screening to Improve Survival in AL Amyloidosis$269,446
R21 · FY2021 · AG · contact PI
Screening to Improve Survival in AL Amyloidosis$245,816
R21 · FY2020 · AG · contact PI